Nanox Imaging Ltd. (NASDAQ: NNOX) has signed a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement, announced in a press release, marks Nanox's third Latin American market this year, following Argentina and Peru, and underscores the company's strategy to drive the global transition to preventive health care through affordable, scalable imaging solutions.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship positions Nanox to leverage SOLME's established ties with the CCSS to facilitate adoption of the Nanox.ARC within Costa Rica's public healthcare system.
Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and demonstration of the system's benefits before broader deployment. The agreement's success could serve as a model for other markets, particularly in regions where access to advanced imaging is limited.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Unlike traditional CT scanners, which are expensive and require specialized infrastructure, the Nanox.ARC aims to provide 3D imaging at a lower cost and with a smaller footprint, making it suitable for a wider range of clinical settings. By expanding access to 3D imaging, Nanox seeks to enable earlier detection of disease and improve patient outcomes.
Nanox's broader ecosystem includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
The Costa Rica agreement is part of Nanox's vision to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
For investors, the deal signals progress in Nanox's commercialization efforts and its ability to penetrate new markets. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX. As Nanox continues to expand its global footprint, the Costa Rica agreement could contribute to revenue growth and further validate its technology in diverse healthcare environments.
